Gene · 9388
LIPG: lipase G, endothelial type
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. LIPG: lipase G, endothelial type. Genes, record 9388. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/9388
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9Y5X9 | Endothelial lipase | 500 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents88
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4705273 A2 | 2026-03-11 | 519 | Q9Y5X9 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 51825 | Q9Y5X9 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 1866 | Q9Y5X9 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 225 | Q9Y5X9 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 1452 | Q9Y5X9 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 7910 | Q9Y5X9 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 6901 | Q9Y5X9 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 6901 | Q9Y5X9 | Espacenet |
| JP 2025519096 A | 2025-06-24 | 225 | Q9Y5X9 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 1452 | Q9Y5X9 | Espacenet |
1 to 10 of 88
See all 88 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,150
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | LIPG papers | Newest fiscal year |
|---|---|---|---|
| P30DK017047 | Diabetes Research Center | 7 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 5 | 2025 |
| P01HL151328 | Triglycerides, Diabetes and Cardiovascular Disease | 4 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| R01HL109946 | Using genetics to discover mechanisms of abdominal aortic aneurysm | 4 | 2025 |
| T32HG002536 | Training Grant in Genomic Analysis and Interpretation | 4 | 2025 |
| ZIAHG000024 | Genetic analysis of type II diabetes | 4 | 2025 |
| ZIAHL006095 | Development of Apo Mimetic Peptides for the Treatment Cardiovascular Disease | 4 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 3 | 2025 |
1 to 10 of 1,150Source NIH's project files
See all 1,150 nih grantsPapers1,360
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Angiopoietin-Like Proteins 3 and 4 and Their Target Lipases in CKD: A Drug-Target Mendelian Randomization Study. | Am J Kidney Dis | 2026 | 42772348 | PubTator, text mining | PubMed |
| Association of ABCA1 and LIPG Polymorphisms with Coronary Heart Disease in a Chinese Han Population: A Case-Control Study with Sex-Stratified Analysis. | Int J Gen Med | 2026 | 42553736 | PubTator, text mining | PubMed |
| An Integrated Multi-omics Single Cell Atlas of the Human RPE and Choroid. | bioRxiv | 2026 | 42539169 | PubTator, text mining | PubMed |
| Single-blastomere transcriptomics identifies NR5A2-associated metabolic genes during porcine zygotic genome activation. | Theriogenology | 2026 | 42497609 | PubTator, text mining | PubMed |
| Size-Resolved Lipoprotein Fatty Acid Content as a Novel Nuclear Magnetic Resonance-Derived Trait Specifically Associates with Genetic Variants That Control Fatty Acid Metabolism. | J Proteome Res | 2026 | 42365607 | PubTator, text mining | PubMed |
| Integrated metabolomic and transcriptomic analysis identifies enhanced phosphatidylcholine metabolism in placenta accreta spectrum. | BMC Pregnancy Childbirth | 2026 | 42337473 | PubTator, text mining | PubMed |
| Immunogenetic modulation of endothelial inflammation by the LIPG -384A/C promoter variant influences COVID-19 severity. | Front Immunol | 2026 | 42317324 | PubTator, text mining | PubMed |
| Endothelial Lipase RS3744843 Polymorphism and Lipid Profile in Bechet's Disease Patients. | Tunis Med | 2026 | 42246713 | PubTator, text mining | PubMed |
| Drug targets for lipid modification and risk of type 2 diabetes: a cis-Mendelian randomization study. | Cardiovasc Diabetol | 2026 | 42135799 | PubTator, text mining | PubMed |
| Altered small dense LDL profiles in long-standing controlled type 1 diabetes. | Front Endocrinol (Lausanne) | 2026 | 42022901 | PubTator, text mining | PubMed |
1 to 10 of 1,360
See all 1,360 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/9388
GET https://conductscience.org/api/genes/v1/9388/patents?page=2